Tércia Alves

575 citations
10 papers · 470 indexed · h-index 9
Topics
Cell Adhesion Molecules Research (4 papers)Glioma Diagnosis and Treatment (2 papers)Protease and Inhibitor Mechanisms (2 papers)

In The Last Decade

Tércia Alves

10 papers receiving 468 citations

Peers

Tércia Alves
Comparison fields: 5 of 75
  • Molecular Biology 246
  • Genetics 114
  • Cancer Research 83
  • Cell Biology 70
  • Oncology 67
Replace Sami Khoshyomn with:
Sami Khoshyomn United States
Lucy Paradiso Australia
Shengping Yu China
Xifeng Fei China
Brian Golbourn Canada
Ligaya Pen United States
Fenghua Zhou China
Chiara Calatozzolo Italy
Jiřina Procházková Czechia
Ilya V. Pyko Japan
Tércia Alves relative to Sami Khoshyomn United States Sami Khoshyomn's profile →
Citations per field
00.5×4.2×
Sami Khoshyomn · 1×
Citations per year

Countries citing papers authored by Tércia Alves

Since Specialization
Citations

This map shows the geographic impact of Tércia Alves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tércia Alves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tércia Alves more than expected).

Fields of papers citing papers by Tércia Alves

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tércia Alves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tércia Alves. The network helps show where Tércia Alves may publish in the future.

Co-authorship network of co-authors of Tércia Alves

This figure shows the co-authorship network connecting the top 25 collaborators of Tércia Alves. A scholar is included among the top collaborators of Tércia Alves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tércia Alves. Tércia Alves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 8
2 122
3 1
4 19
5 105
6 22
7 50
8
Inhibition of MAPK/ERK, PKC and CaMKII signaling blocks cytolysin-induced human glioma cell death.
21
9 54
10 68

About Tércia Alves

Tércia Alves is a scholar working on Immunology and Allergy, Developmental Neuroscience and Cancer Research, having authored 10 papers that have together received 470 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (4 papers), Glioma Diagnosis and Treatment (2 papers) and Protease and Inhibitor Mechanisms (2 papers). The work is most often cited by research in Genetics (114 citations), Immunology and Allergy (38 citations) and Neurology (51 citations). Tércia Alves has collaborated with scholars based in Brazil, France and United States. Frequent co-authors include Vivaldo Moura‐Neto, Helena L. Borges, Rossana C. Soletti, Suzana Assad Kahn, Flávia Regina Souza Lima, Luciana Romão, Verônica Morandi, Anna Carolina Carvalho da Fonseca, Jane Faria and Luiz Gustavo Dubois. Their work appears in journals such as Brain Research, Experimental Cell Research and Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026